Search Results - "Kwon, Hyunjoo"
-
1
Yes‐Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic Steatohepatitis
Published in Hepatology (Baltimore, Md.) (01-07-2020)“…Background and Aims Yes‐associated protein (YAP) plays an important role in hepatocarcinogenesis, although the potential role of YAP in non‐neoplastic liver…”
Get full text
Journal Article -
2
Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation
Published in The American journal of pathology (01-10-2017)“…Aberrant expression and regulation of miRNAs have been implicated in multiple stages of tumorigenic processes. The current study was designed to explore the…”
Get full text
Journal Article -
3
Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway
Published in The American journal of pathology (01-10-2017)“…Aberrant expression and regulation of miRNAs have been implicated in multiple stages of tumorigenic processes. The current study was designed to explore the…”
Get full text
Journal Article -
4
The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway
Published in Hepatology (Baltimore, Md.) (01-10-2020)“…Background and Aims Cholangiocarcinoma (CCA) is a highly malignant epithelial tumor of the biliary tree with poor prognosis. In the current study, we present…”
Get full text
Journal Article -
5
Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease
Published in Hepatology (Baltimore, Md.) (01-04-2016)“…Hedgehog (Hh) signaling plays a critical role in liver development, regeneration, injury repair, and carcinogenesis. Activation of Hh signaling has been…”
Get full text
Journal Article -
6
A Transforming Growth Factor‐β and H19 Signaling Axis in Tumor‐Initiating Hepatocytes That Regulates Hepatic Carcinogenesis
Published in Hepatology (Baltimore, Md.) (01-04-2019)“…Functions of transforming growth factor‐β (TGF‐β) in the liver vary depending on specific cell types and their temporal response to TGF‐β during different…”
Get full text
Journal Article -
7
EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes
Published in The American journal of pathology (01-12-2022)“…Cholangiocarcinoma (CCA) is a highly malignant cancer of the biliary tree. Although studies have implicated enhancer of Zeste homolog 2 (EZH2) in CCA growth,…”
Get full text
Journal Article -
8
Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122
Published in Oncotarget (01-12-2015)“…Although altered metabolic pathway is an important diagnostic maker and therapeutic target in cancer, it is poorly understood in cancer stem cells (CSCs). Here…”
Get full text
Journal Article -
9
HM15912, a Novel Long-Acting Glucagon-Like Peptide-2 Analog, Improves Intestinal Growth and Absorption Capacity in a Male Rat Model of Short Bowel Syndrome
Published in The Journal of pharmacology and experimental therapeutics (01-02-2023)“…Extensive bowel resection caused by various diseases that affect the intestines, such as Crohn's disease, volvulus, and cancer, leads to short bowel syndrome…”
Get full text
Journal Article -
10
-
11
-
12
-
13
-
14
Yes‐associated protein (YAP) in Kupffer cells enhances the production of pro‐inflammatory cytokines and promotes the development of non‐alcoholic steatohepatitis
Published in The FASEB journal (01-04-2020)“…Abstract only…”
Get full text
Journal Article -
15
The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway
Published in The FASEB journal (01-04-2020)“…Abstract only…”
Get full text
Journal Article -
16
655-P: Multitarget Engagement Effect of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Animal Model of NASH
Published in Diabetes (New York, N.Y.) (01-06-2021)“…NASH is a complex disease progressed by multiple mechanism. To date, no approved drug is available due to unsatisfied efficacy. Of note, recent studies…”
Get full text
Journal Article -
17
Multi-target engagement effect of a novel long-acting Glucagon/ GIP/GLP-1 triple agonist, HM15211, in animal model of NASH/ fibrosis
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
18
Adult Hepatocytes Are Hedgehog-Responsive Cells in the Setting of Liver Injury: Evidence for Smoothened-Mediated Activation of NF-κB/Epidermal Growth Factor Receptor/Akt in Hepatocytes that Counteract Fas-Induced Apoptosis
Published in The American journal of pathology (01-11-2018)“…Although hedgehog (Hh) signaling pathway is inactive in adult healthy liver, it becomes activated during acute and chronic liver injury and, thus, modulates…”
Get full text
Journal Article -
19
1830-P: Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in CDHFD-Induced NASH and Fibrosis Mice
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Nonalcoholic steatohepatitis (NASH) is a progressive liver disease characterized by steatosis and inflammation, which results in fibrosis. In particular,…”
Get full text
Journal Article -
20
YAP in Kupffer cells enhances the production of pro-inflammatory cytokines and promotes the development of non-alcoholic steatohepatitis
Published in Hepatology (Baltimore, Md.) (11-04-2020)“…Yes-associated protein (YAP) plays an important role in hepatocarcinogenesis, although the potential role of YAP in non-neoplastic liver diseases remains…”
Get full text
Journal Article